Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-09-03 Option Award | 2021-09-08 5:00 pm | N/A 2031-09-03 | Oncotelic Therapeutics Inc. | OTLC | MAIDA ANTHONY E III Chief Clin. Ops. Officer | 600,000 | $0 | 600,000 (Direct) | View |
| 2021-07-08 Option Award | 2021-07-16 5:39 pm | 2021-07-08 2031-07-08 | Oncotelic Therapeutics Inc. | OTLC | MAIDA ANTHONY E III CHIEF CLINICAL OFFICER | 400,000 | $0 | 1,537,314 (Direct) | View |
| 2021-03-31 Conversion | 2021-07-16 5:39 pm | N/A N/A | Oncotelic Therapeutics Inc. | OTLC | MAIDA ANTHONY E III CHIEF CLINICAL OFFICER | 939,584 | $0 | 1,537,314 (Direct) | View |
Ownership | 2020-05-21 8:29 pm | N/A N/A | MATEON THERAPEUTICS INC | MATN | MAIDA ANTHONY E III Director | 0 | $0 | 1,137,314 (Direct) | View |
| 2020-04-24 Option Award | 2020-05-04 5:55 pm | 2020-04-24 2030-04-24 | INNOVATE BIOPHARMACEUTICALS INC. | NMTR | MAIDA ANTHONY E III Director | 25,000 | $0 | 25,000 (Direct) | View |